430 related articles for article (PubMed ID: 18402526)
21. No clear evidence for adjuvant therapy in people with stage II colon cancer.
Wille-Jørgensen P
Cancer Treat Rev; 2005 Apr; 31(2):147-50. PubMed ID: 15847983
[No Abstract] [Full Text] [Related]
22. Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial.
Taieb J; Puig PL; Bedenne L
Expert Rev Anticancer Ther; 2008 Feb; 8(2):183-9. PubMed ID: 18279058
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy for colon cancer: present and perspectives.
De Dosso S; Sessa C; Saletti P
Cancer Treat Rev; 2009 Apr; 35(2):160-6. PubMed ID: 19013023
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5-fluorouracil adjuvant treatment of colon cancer.
Kelder W; Hospers GA; Plukker JT
Expert Rev Anticancer Ther; 2006 May; 6(5):785-94. PubMed ID: 16759168
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy of stage III colon cancer.
Benson AB
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S74-7. PubMed ID: 16399437
[TBL] [Abstract][Full Text] [Related]
26. [Should adjuvant chemotherapy be also used in Dukes stage B2 colon cancer?].
Porschen R
Z Gastroenterol; 1996 Sep; 34(9):549-51. PubMed ID: 8975491
[No Abstract] [Full Text] [Related]
27. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Land SR; Kopec JA; Cecchini RS; Ganz PA; Wieand HS; Colangelo LH; Murphy K; Kuebler JP; Seay TE; Needles BM; Bearden JD; Colman LK; Lanier KS; Pajon ER; Cella D; Smith RE; O'Connell MJ; Costantino JP; Wolmark N
J Clin Oncol; 2007 Jun; 25(16):2205-11. PubMed ID: 17470850
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemotherapy for stage II colon cancer: the time has come.
Mamounas EP
Eur J Surg Oncol; 2000 Dec; 26(8):725-9. PubMed ID: 11087634
[No Abstract] [Full Text] [Related]
29. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment.
Kornmann M; Formentini A; Ette C; Henne-Bruns D; Kron M; Sander S; Baumann W; Kreuser ED; Staib L; Link KH
Eur J Surg Oncol; 2008 Dec; 34(12):1316-21. PubMed ID: 18313881
[TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.
Oncology (Williston Park); 2004 Sep; 18(10):1313. PubMed ID: 15526833
[No Abstract] [Full Text] [Related]
32. [Surgery and multidisciplinary treatment for colorectal cancer].
Sakamoto J; Kato J; Yasue M
Gan To Kagaku Ryoho; 1998 Jan; 25(2):208-15. PubMed ID: 9474930
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant therapy for colon cancer in the new millenium.
Rao S; Cunningham D
Scand J Surg; 2003; 92(1):57-64. PubMed ID: 12705552
[TBL] [Abstract][Full Text] [Related]
34. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
[TBL] [Abstract][Full Text] [Related]
36. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
Benson AB
Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
[TBL] [Abstract][Full Text] [Related]
37. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer.
Lamberti C; Sauerbruch T; Glasmacher A
Cancer Treat Rev; 2005 Dec; 31(8):648-52. PubMed ID: 16289340
[No Abstract] [Full Text] [Related]
39. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.
Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I
Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy in colon cancer.
Lombardi L; Gebbia V; Silvestris N; Testa A; Colucci G; Maiello E
Oncology; 2009; 77 Suppl 1():50-6. PubMed ID: 20130432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
